
11.81 Delayed Data As of Jan 20 | ![]() Today’s Change | 6.02 Today|||52-Week Range 17.60 | +2.61% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +69.35% increase from the last price of 11.81.
The current consensus among 5 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.